Evidence map›Paper›PMID 33531385›Full record

ArticlemBio2021

An Antibiotic-Impacted Microbiota Compromises the Development of Colonic Regulatory T Cells and Predisposes to Dysregulated Immune Responses.

Xiaozhou Zhang, Timothy C Borbet, Angela Fallegger, Matthew F Wipperman, Martin J Blaser, Anne Müller

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antibiotics promote susceptibility tobioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Xiaozhou Zhang *Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Timothy C Borbet *Department of Pathology, New York University School of Medicine, New York, New York, USA.
Angela Fallegger *Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Matthew F WippermanImmunology Program, Sloan Kettering Institute, New York, USA.
Martin J BlaserCenter for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey, USA martin.blaser@cabm.rutgers.edu mueller@imcr.uzh.ch.ORCID 0000-0003-2447-2443
Anne MüllerInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland martin.blaser@cabm.rutgers.edu mueller@imcr.uzh.ch.
University of Zurich · CHCornell University · USNew York University · USRutgers, The State University of New Jersey · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
NRSA Training CoreTL1TR001447 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MICOLI, KEITH J. · 2015 to 2025
$5.9M
J. NRSA Training CoreTL1TR002386 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Genevieve Giny Fouda Amou ou · 2017 to 2026
$5.8M
Clinical and Transtional Science InstituteTL1TR000144 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$643k
NCATS NIH HHS TL1 TR000144NCATS NIH HHS TL1 TR001447NCATS NIH HHS TL1 TR002386NCATS NIH HHS UL1 TR001445NCI NIH HHS P30 CA008748NIAID NIH HHS T32 AI007180
6 · The paper itself

Abstract

Antibiotic exposure early in life and other practices impacting the vertical transmission and ordered assembly of a diverse and balanced gut microbiota are associated with a higher risk of immunological and metabolic disorders such as asthma and allergy, autoimmunity, obesity, and susceptibility to opportunistic infections. In this study, we used a model of perinatal exposure to the broad-spectrum antibiotic ampicillin to examine how the acquisition of a dysbiotic microbiota affects neonatal immune system development. We found that the resultant dysbiosis imprints in a manner that is irreversible after weaning, leading to specific and selective alteration of the colonic CD4

Indexed as

Gastrointestinal MicrobiomeAnimalsAnti-Bacterial AgentsColonDendritic CellsDysbiosisFemaleMiceMice, Inbred C57BLT-Lymphocytes, RegulatoryAnti-Bacterial Agentsbroad-spectrum antibioticsCD4 T cellscolonic regulatory T cellsdysregulated immune responsedysregulated Th1 responsesmetabolic disordersmicrobiotatransmaternal exposureTreg deficiency

Identifiers

PMID33531385
PMCPMC7858066
OpenAlexW3127662392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.